US administration considers allowing compounding pharmacies to sell restricted peptides
The Trump administration considers temporarily allowing compounding pharmacies to sell certain restricted peptides despite FDA safety warnings.
The Trump administration considers temporarily allowing compounding pharmacies to sell certain restricted peptides despite FDA safety warnings.